BioSpace News Archive

Bernard Bailey, chairman of the board for Analogic, will host the meeting.

The approval was based on results of a U.S. randomized, pivotal study comparing the Light Adjustable Lens to a commercially available monofocal lens in 600 patients with pre-existing astigmatism.

PARADIGME is designed to generate the clinical data needed to support the filing of the best Betalutin dosage regimen for this patient population.

Mundipharma will have exclusive rights to the product in more than 35 African markets and countries.

The data confirmed no significant safety issues and that efficacy appeared to be comparable to existing commercial IVIG products.

The accord allows the two companies to provide software/hardware solutions to the Indian pharma industry that meet serialization and traceability regulations.

Company will also sponsor continuing education workshops that will address utilizing dental lasers in the treatment of periodontal conditions.

The release will be available at the 2017 RSNA Show at Chicago’s McCormick Place November 26th-30th.

Their results could lead the way to a new therapeutic target to treat pancreatitis, a known risk factor for pancreatic cancer.

AdapTEK allows a surgeon to create a range of interbody devices to their individual specifications that are then produced by Medicrea with complete in-house additive manufacturing capabilities and total control of the internal process without any of the limitations associated with subcontracting external suppliers.